GSK Price to Free Cash Flow Ratio 2010-2023 | GSK
Historical price to free cash flow ratio values for GSK (GSK) since 2010.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| GSK Price to Free Cash Flow Ratio Historical Data |
| Date |
Stock Price |
TTM FCF per Share |
Price to FCF Ratio |
| 2023-06-02 |
34.11 |
|
15.34 |
| 2023-03-31 |
35.23 |
$2.22 |
15.85 |
| 2022-12-31 |
34.46 |
$3.88 |
8.88 |
| 2022-09-30 |
28.57 |
$5.08 |
5.62 |
| 2022-06-30 |
52.26 |
$6.21 |
8.41 |
| 2022-03-31 |
51.89 |
$6.20 |
8.37 |
| 2021-12-31 |
51.77 |
$4.76 |
10.88 |
| 2021-09-30 |
44.30 |
$4.58 |
9.67 |
| 2021-06-30 |
45.61 |
$3.48 |
13.10 |
| 2021-03-31 |
40.33 |
$4.26 |
9.47 |
| 2020-12-31 |
40.84 |
$4.64 |
8.80 |
| 2020-09-30 |
41.21 |
$4.48 |
9.19 |
| 2020-06-30 |
44.13 |
$5.36 |
8.23 |
| 2020-03-31 |
40.52 |
$4.56 |
8.88 |
| 2019-12-31 |
49.59 |
$4.36 |
11.38 |
| 2019-09-30 |
44.54 |
$4.91 |
9.08 |
| 2019-06-30 |
41.29 |
$4.74 |
8.72 |
| 2019-03-31 |
42.61 |
$4.72 |
9.02 |
| 2018-12-31 |
38.39 |
$4.86 |
7.89 |
| 2018-09-30 |
39.88 |
$3.92 |
10.18 |
| 2018-06-30 |
39.54 |
$3.79 |
10.45 |
| 2018-03-31 |
37.85 |
$3.55 |
10.65 |
| 2017-12-31 |
33.76 |
$3.69 |
9.16 |
| 2017-09-30 |
38.10 |
$2.99 |
12.73 |
| 2017-06-30 |
39.95 |
$2.64 |
15.15 |
| 2017-03-31 |
38.62 |
$2.29 |
16.87 |
| 2016-09-30 |
38.51 |
$2.51 |
15.35 |
| 2016-06-30 |
38.30 |
$1.78 |
21.52 |
| 2016-03-31 |
35.41 |
$-7.04 |
0.00 |
| 2015-12-31 |
34.17 |
$1.00 |
34.30 |
| 2015-09-30 |
32.13 |
$1.75 |
18.40 |
| 2015-06-30 |
34.36 |
$2.39 |
14.35 |
| 2015-03-31 |
37.57 |
$10.99 |
3.42 |
| 2014-12-31 |
34.29 |
$3.42 |
10.04 |
| 2014-09-30 |
36.39 |
$3.52 |
10.33 |
| 2014-06-30 |
41.77 |
$4.13 |
10.11 |
| 2014-03-31 |
41.25 |
$4.79 |
8.61 |
| 2013-12-31 |
40.67 |
$4.98 |
8.16 |
| 2013-09-30 |
37.77 |
$4.65 |
8.13 |
| 2013-06-30 |
37.22 |
$2.83 |
13.14 |
| 2013-03-31 |
34.57 |
$2.91 |
11.86 |
| 2012-12-31 |
31.55 |
$2.78 |
11.37 |
| 2012-09-30 |
33.11 |
$2.94 |
11.24 |
| 2012-06-30 |
32.27 |
$4.64 |
6.95 |
| 2012-03-31 |
31.42 |
$4.36 |
7.20 |
| 2011-12-31 |
31.35 |
$4.33 |
7.24 |
| 2011-09-30 |
28.01 |
$3.85 |
7.28 |
| 2011-06-30 |
28.76 |
$2.94 |
9.77 |
| 2011-03-31 |
25.44 |
$3.56 |
7.14 |
| 2010-12-31 |
25.57 |
$4.38 |
5.84 |
| 2010-09-30 |
25.43 |
$4.59 |
5.54 |
| 2010-06-30 |
21.61 |
$5.69 |
3.80 |
| 2010-03-31 |
24.17 |
$5.29 |
4.57 |
| 2009-12-31 |
26.11 |
$4.84 |
5.40 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$69.839B |
$36.279B |
|
GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many more. GSK plc, formerly known as GLAXOSMITHKLINE, is based in Brentford, the United Kingdom.
|
